Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion—A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM.
暂无分享，去创建一个
T. Zander | E. Maiello | R. Hofheinz | D. Strumberg | S. Al-Batran | T. Gaiser | D. Pink | E. Goekkurt | T. Goetze | C. Pauligk | G. Siegler | J. Potenberg | F. Vita | N. Homann | H. Kopp | D. Sookthai | M. Schenk | H. Schmalenberg | U. Bankstahl | S. Angermeier